Grayson B. Lipford
President chez Janus Biotherapeutics, Inc.
Profil
Grayson B.
Lipford is currently the President, Chief Scientific Officer & Director at Janus Biotherapeutics, Inc. He previously worked as the Vice President-Basic Research at Coley Pharmaceutical Group, Inc. and as the Vice President-Discovery at Selecta Biosciences, Inc. Lipford received his undergraduate degree from Virginia Commonwealth University and his doctorate from Eastern Virginia Medical School.
Postes actifs de Grayson B. Lipford
| Sociétés | Poste | Début |
|---|---|---|
Janus Biotherapeutics, Inc.
 Janus Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Janus Biotherapeutics, Inc. is an autoimmunity therapeutics company, which develops orally available compounds for the treatment of autoimmune diseases. The company was founded by Joseph Baron and Grayson Lipford and is headquartered in Wellesley, MA. | President | 01/04/2011 |
Anciens postes connus de Grayson B. Lipford
| Sociétés | Poste | Fin |
|---|---|---|
Coley Pharmaceutical Group, Inc.
 Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Corporate Officer/Principal | - |
| CARTESIAN THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formation de Grayson B. Lipford
| Virginia Commonwealth University | Undergraduate Degree |
| Eastern Virginia Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
Coley Pharmaceutical Group, Inc.
Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Health Technology |
Janus Biotherapeutics, Inc.
Janus Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Janus Biotherapeutics, Inc. is an autoimmunity therapeutics company, which develops orally available compounds for the treatment of autoimmune diseases. The company was founded by Joseph Baron and Grayson Lipford and is headquartered in Wellesley, MA. | Health Technology |
